Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Unseparated fraction |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Enriched Pan-DCs |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Non-DCs |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Unseparated fraction |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Enriched Pan-DCs |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Non-DCs |
Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. | Pan-DC Enrichment Kit, humanFigure 1Pre-enrichment of untouched Pan-DCs from human PBMCs using the Pan-DC Enrichment Kit, human, a MidiMACS Separator and an LS Column. The cells were fluorescently stained with CD303 (BDCA-2)-FITC, CD141 (BDCA-3)-APC, CD1c (BDCA-1)-PE, and CD20-PerCP and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris, dead cells, and B cells were excluded from the analysis based on scatter signals, propidium iodide fluorescence, and CD20 expression. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2022 Miltenyi Biotec and/or its affiliates. All rights reserved.